Published in Infection on September 12, 2008
Non-adherence to antimicrobial treatment guidelines results in more broad-spectrum but not more appropriate therapy. Eur J Clin Microbiol Infect Dis (2011) 0.92
Following guidelines under stress. Infection (2008) 0.75
Cranberry juice and urinary tract infection. Clin Infect Dis (2004) 2.68
Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel. Isr Med Assoc J (2000) 2.22
Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis (2004) 2.17
Risk of infection and death among post-splenectomy patients. J Infect (2001) 2.06
Myalgia, fever, abnormal muscle enzymes and blue urine in a farmworker from Thailand. Isr Med Assoc J (2001) 1.99
Cooperation between STAT3 and c-jun suppresses Fas transcription. Mol Cell (2001) 1.97
Expression of a maize cell wall hydroxyproline-rich glycoprotein gene in early leaf and root vascular differentiation. Plant Cell (1990) 1.87
Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis (2002) 1.59
Variability in outpatient antimicrobial consumption in Israel. Infection (2010) 1.55
Usefulness of blood cultures in the management of febrile patients in long-term care facilities. Eur J Clin Microbiol Infect Dis (2005) 1.51
Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment. Antimicrob Agents Chemother (2002) 1.50
Home intravenous antibiotic therapy programme, 1999. J Infect (2001) 1.46
Bone marrow aplasia associated with ticlopidine therapy. Am J Hematol (1993) 1.43
[Community acquired urinary tract infection among hospitalized children in northern Israel: pathogens, susceptibility patterns and urinary tract anomalies]. Harefuah (2003) 1.40
Risk factors for infection in fracture war wounds (1973 and 1982 wars, Israel) Mil Med (1991) 1.38
STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2. Development (2001) 1.36
Letter: Penile size in the newborn infant. J Pediatr (1975) 1.28
Recurrent nephrotic syndrome associated with Kimura's disease in a young non-Oriental male. Nephron (1994) 1.28
DNA methylation in 5-aza-2'-deoxycytidine-resistant variants of C3H 10T1/2 C18 cells. Mol Cell Biol (1984) 1.24
Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections. J Infect (1991) 1.21
Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection. J Infect (1997) 1.21
Failure of prolonged treatment with ciprofloxacin in acute infections due to Brucella melitensis. J Antimicrob Chemother (1990) 1.19
Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis (1999) 1.17
Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone. J Biol Chem (1995) 1.15
Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease. J Rheumatol (1999) 1.12
Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis (2005) 1.10
Antimicrobial susceptibility of community-acquired uropathogens in northern Israel. Int J Antimicrob Agents (2001) 1.10
Variable 5-methylcytosine levels in human tumor cell lines and fresh pediatric tumor explants. Cancer Res (1983) 1.05
Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection (2008) 1.03
Vibrio infection in Israel due to changes in fish marketing. Lancet (1996) 1.03
Endocarditis caused by Blastoschizomyces capitatus and taxonomic review of the genus. J Clin Microbiol (1992) 1.03
Urinary tract infection among women aged 40 to 65: behavioral and sexual risk factors. J Clin Epidemiol (2001) 1.03
Prevalence of cognitive dysfunction and hypothyroidism in an elderly community population. Isr J Med Sci (1996) 1.01
Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clin Infect Dis (2003) 1.01
Screening with faecal occult blood test (FOBT) for colorectal cancer: assessment of two methods that attempt to improve compliance. Eur J Cancer Prev (2001) 1.01
Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med (1996) 0.99
Epidemiological and serological studies in HIV-infected Ethiopian immigrants to Israel. Acta Paediatr Suppl (1994) 0.99
An outbreak of Shigella sonnei infection due to contamination of a municipal water supply in northern Israel. J Infect (1991) 0.99
Prevalence and risk factors for asymptomatic bacteriuria in women with Type 2 diabetes mellitus. Diabet Med (2006) 0.97
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
West Nile fever encephalitis. Isr J Med Sci (1981) 0.94
Typhoid fever in Ethiopian immigrants to Israel and native-born Israelis: a comparative study. Clin Infect Dis (1993) 0.94
Failure of ceftriaxone in the treatment of acute brucellosis. Clin Infect Dis (1992) 0.94
The classic approach to diagnosis of vulvovaginitis: a critical analysis. Infect Dis Obstet Gynecol (2001) 0.93
Bacteraemia in a community and a university hospital. J Antimicrob Chemother (1995) 0.93
Nosocomial bacteremia due to Acinetobacter calcoaceticus. Infection (1982) 0.92
Chronic Q fever and severe thrombocytopenia in a pregnant woman. Am J Med (1988) 0.91
Infection with Streptococcus milleri. J Infect (1987) 0.91
Hereditary complement deficiency in survivors of meningococcal disease: high prevalence of C7/C8 deficiency in Sephardic (Moroccan) Jews. Q J Med (1987) 0.91
Schönlein-Henoch syndrome in patients with familial Mediterranean fever. Arthritis Rheum (1982) 0.91
A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. Arch Intern Med (1996) 0.90
Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells. Endocrinology (1996) 0.90
Subacute necrotizing fasciitis caused by gas-producing Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (2003) 0.90
Unusual portal of entry of Vibrio vulnificus: evidence of its prolonged survival on the skin. Clin Infect Dis (2002) 0.90
Campylobacter bacteremia and pneumonia in two splenectomized patients. Eur J Clin Microbiol Infect Dis (1999) 0.89
Molecular analysis of a putative transposable retroelement from the Zea genus with internal clusters of tandem repeats. DNA Res (1995) 0.89
[Infection by Vibrio vulnificus after a prick from from the spine of a Tilapia]. Harefuah (1997) 0.88
Diabetes mellitus and hypertension as risk factors for early diffuse idiopathic skeletal hyperostosis (DISH). Osteoarthritis Cartilage (2008) 0.87
Thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in three siblings. Arch Dis Child (1988) 0.87
Familial pattern of infection with hepatitis B virus among immigrating Ethiopian Jews in Israel. Eur J Epidemiol (1998) 0.86
Seasonal variation in Escherichia coli bloodstream infections in northern Israel. Clin Microbiol Infect (2010) 0.86
Extraosseous accumulation of 99mTc-MDP in a benign intrapulmonary calcified focus. Eur J Nucl Med (1985) 0.85
[Diagnosis and treatment of streptococcal pharyngitis]. Harefuah (1989) 0.85
Risk factors for non-Escherichia coli community-acquired bacteriuria. Infection (2012) 0.85
Complementary medicine and psoriasis: linking the patient's outlook with evidence-based medicine. Dermatology (2003) 0.84
Malaria and Borrelia co-infection. J Travel Med (2000) 0.84
[Familial parinaud oculo-glandular syndrome in cat-scratch disease]. Harefuah (2000) 0.84
Bone scintigraphy in two siblings with pulmonary alveolar microlithiasis. Br J Radiol (1985) 0.83
Extraosseous 99mTc-MDP uptake in squamous cell carcinoma of the pleura. Eur J Nucl Med (1987) 0.83
A retrospective six-year national survey of P. multocida infections in Israel. Scand J Infect Dis (2009) 0.83
Can exaggerated response to a GH provocative test identify patients with partial GH insensitivity syndrome? Eur J Endocrinol (2002) 0.83
Prevalence of markers of infection with hepatitis B and C viruses in immigrants of operation Solomon, 1991. Isr J Med Sci (1993) 0.82
Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women. Antimicrob Agents Chemother (1994) 0.82
Once daily cefixime compared with twice daily trimethoprim/sulfamethoxazole for treatment of urinary tract infection in infants and children. Pediatr Infect Dis J (1992) 0.82
Age-related seroprevalence of Cryptosporidium in northern Israel. Isr Med Assoc J (2000) 0.81
Oral ciprofloxacin treatment of Pseudomonas aeruginosa osteomyelitis. Antimicrob Agents Chemother (1990) 0.81
Iron loading and endocrine functions in nontransfused patients with beta-thalassemia intermedia or sickle-cell thalassemia. Isr J Med Sci (1981) 0.81
Trends in outpatient antibiotic use in Israel during the years 2000-2010: setting targets for an intervention. Infection (2012) 0.81
High-level handwashing compliance in a community teaching hospital: a challenge that can be met! J Hosp Infect (2001) 0.80
Community-acquired and hospital-acquired candiduria: comparison of prevalence and clinical characteristics. Eur J Clin Microbiol Infect Dis (2007) 0.80